3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
3
Pain
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Supratentorial Neoplasms
1
Pain, Intractable
1
Nephrolithiasis
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Leiomyoma
1
Kidney Neoplasms
1
Ileus
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Advanced Malignant Neoplasm
1
Interventions
pembrolizumab
45
Paclitaxel
42
Carboplatin
34
Bevacizumab
18
Specimen Handling
17
Letrozole
16
lenvatinib
13
Magnetic Resonance Spectroscopy
12
dostarlimab
11
Cisplatin
11
Biopsy
11
Taxes
10
olaparib
9
Fulvestrant
9
Doxorubicin
9
abemaciclib
8
Megestrol Acetate
8
Docetaxel
8
durvalumab
7
atezolizumab
7
Nivolumab
7
Gemcitabine
7
Blood Specimen Collection
7
palbociclib
6
Oxaliplatin
6
Observation
6
Fluorouracil
6
niraparib
5
Surveys and Questionnaires
5
Progestins
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Morphine
×
1 year
×
Clear all
No trials found.